Eric Pauwels
Vermögen: 5 Mio $ am 31.07.2026
Vermögen: 5 Mio $ am 31.07.2026
Eric Pauwels is Chief Business Officer at PTC Therapeutics, Inc. since 2020 and has been with the company since 2015.
Formerly, Mr. Pauwels was Chief Commercial Officer & Senior Vice President at NPS Pharmaceuticals, Inc. from 2011 to 2015, Chief Marketing Officer & Senior Vice President at Accuray, Inc., Chief Commercial Officer at Shire Human Genetic Therapies, Inc. in 2010, Vice President-Global Strategic Marketing at Bayer HealthCare Pharmaceuticals, Inc. in 2005, and President at NPS Pharma International Ltd. Education includes undergraduate studies at California State Polytechnic University (Pomona).
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 73’411 ( 0.09% ) | 5 Mio $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | 01.03.2015 |
| Unternehmen | Position | Ende |
|---|---|---|
| NPS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2015 |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Corporate Officer/Principal | 01.01.2010 |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Vertrieb & Marketing | 01.01.2005 |
NPS Pharma International Ltd. | Präsident | - |
| ACCURAY INCORPORATED | Vertrieb & Marketing | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
NPS Pharmaceuticals, Inc.
NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products for the treatments of rare diseases | Health Technology |
PTC Therapeutics, Inc.
PTC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets clinically differentiated medicines for neurodegenerative diseases | Health Technology |
Accuray, Inc.
Accuray, Inc. Medical SpecialtiesHealth Technology Manufactures medical equipment | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
California State Polytechnic University (Pomona)
California State Polytechnic University (Pomona) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NPS Pharma International Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen